Federal contract award
75N93023F00001
TESTING OF A NOVEL INHALED CLOFAZIMINE (CFZ) DRY POWDER FORMULATION IN A MOUSE MODEL OF MYCOBACTERIUM TUBERCULOSIS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | 75N93021D00011 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $788.4K |
| Current contract value | $788.4K |
| Potential contract value / ceiling | $788.4K |
| Start date | Aug 1, 2023 |
| Current end date | Sep 30, 2025 |
| Potential end date | Sep 30, 2025 |
| Latest award activity | May 28, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 28, 2025 | P00003 | $0 | TESTING OF A NOVEL INHALED CLOFAZIMINE (CFZ) DRY POWDER FORMULATION IN A MOUSE MODEL OF MYCOBACTERIUM TUBERCULOSIS |
| Apr 3, 2025 | P00002 | $108.4K | TESTING OF A NOVEL INHALED CLOFAZIMINE (CFZ) DRY POWDER FORMULATION IN A MOUSE MODEL OF MYCOBACTERIUM TUBERCULOSIS |
| Mar 14, 2025 | P00001 | $0 | TESTING OF A NOVEL INHALED CLOFAZIMINE (CFZ) DRY POWDER FORMULATION IN A MOUSE MODEL OF MYCOBACTERIUM TUBERCULOSIS |
| Jul 25, 2023 | 0 | $680.0K | TESTING OF A NOVEL INHALED CLOFAZIMINE (CFZ) DRY POWDER FORMULATION IN A MOUSE MODEL OF MYCOBACTERIUM TUBERCULOSIS |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.